Overview
AI/ML drug discovery platform including COSMOS structure-based foundation model and APEX (Approximate-but-Exhaustive Search) protocol for ultra-fast screening of hyper-scalable virtual combinatorial libraries.
Product and company
Atomwise — Biotechnology is a verified product offering linked to the Brel Digital company profile for Atomwise.
Use cases
AI/ML drug discovery platform including COSMOS structure-based foundation model and APEX (Approximate-but-Exhaustive Search) protocol for ultra-fast screening of hyper-scalable virtual combinatorial libraries.
Target customer
Pharmaceutical and biotechnology R&D teams seeking AI-accelerated hit discovery across kinases, GPCRs, proteases, and nuclear receptor targets.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Generative AI, Healthcare Analytics, Large Language Models, Machine Learning, Predictive Analytics.
Sources and references
- Official product / company source: https://numerionlabs.ai/numerion-labs-publishes-breakthrough-ai-research-on-ultra-fast-screening-of-hyper-scalable-virtual-libraries-with-nvidia/
- Supporting source: https://numerionlabs.ai/team/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- AI/ML drug discovery platform including COSMOS structure-based foundation model and APEX (Approximate-but-Exhaustive Sear
- COSMOS structure-based foundation model
Extracted from the linked company product description already verified on Brel. No capabilities were invented.